<p align="justify"><strong>Gapping up</strong><br /><u>In reaction to strong earnings/guidance/SSS:</u> HOTT +16.4% (announces a $1.00 per share special one-time cash dividend and a $0.07 per share regular quarterly dividend), STRM +9.0% (light volume), , WDFC +7.6%, SMSC +6.2%, GPS +4.3%, ARO +4.0% (sees Q1 EPS of ~$0.44 vs $0.41 Thomson Reuters consensus), BBBY +3.4%, MDRX +3.0%, NAV +2.8%, TGT +1.8% (also issues upside Q1 guidance), LTD +1.8%, M +0.8%.</p><p align="justify"><u>M&A news:</u> LCC +20.5% and UAUA +7.4% (United and US Airways Said to Be in Merger Talks - NY Times).</p><p align="justify"><u>Select airline related stocks trading higher boosted by LCC/UAUA merger news</u>: AMR +3.9%, JBLU +2.6%, LUV +2.3%, RJET +1.6%, DAL +1.3%.</p><p align="justify"><u>Other news:</u> CIGX +16.9% (pre-market strength attributed to James Altucher's blog on Seeking Alpha; shares trading at $2.84 in pre-market), HUSA +6.8% (addresses stock trading volume and price; "attributable to an internet posting questioning the valuation of the company's holdings"), DM +4.1% (will replace NewMarket in the S&P SmallCap 600 index), HOKU +3.6% (starts polysilicon ramp-up at Pocatello facility), CVBF +3.4% (Cramer makes positive comments on MadMoney), VRTX +2.5% (New England Journal of Medicine publishes PROVE 3 trial showing telaprevir-based regimens significantly increased sustained viral response rates in patients who did not achieve SVR with prior HCV therapy), CYN +1.3% (Cramer makes positive comments on MadMoney), MEE +1.3% (still checking), PANL +0.7% (Awarded SBIR Phase II Contract from the National Science Foundation for Novel Encapsulation Technology for Flexible Electronics)</p><p align="justify"><u>Analyst comments:</u> SOMX +5.4% (initiated Outperform and $12 tgt at Oppenheimer, initiated with a Buy at Jefferies), ABC +1.6% ( coverage assumed with a Buy from Hold at Citigroup), ATHN +1.5% (coverage assumed with a Hold from Sell at Citigroup).</p><p align="justify"><strong>Gapping down</strong><br /><u>In reaction to disappointing earnings/guidance/SSS:</u> CML -15.5% (also downgraded to Neutral from Buy at Merriman, downgraded to Market Perform from Outperform at Northland Securities), LYTS -14.3% (light volume), APOG -12.5%, SCSC -9.1%, ANF -4.5%, JCP -4.4%, ZUMZ -3.4% (also downgraded to Neutral from Outperform at Wedbush), ATK -1.9%, AEO -1.6%, COST -1.1% (light volume).</p><p align="justify"><u>Select financial related names showing weakness:</u> NBG -6.2% (Markets dump Greek assets as debt fears grow - Reuters.com), UBS -2.8%, CS -2.7%, LYG -2.6%, STD -2.4%, AIB -2.1%, MI -2.1%, ING -2.0%.</p><p align="justify"><u>Select metals/mining stocks trading lower</u>: MT -2.5%, AU -2.2%, HMY -2.2%, BBL -1.7%, BHP -1.3%, RTP -1.3%, VALE -1.1%.</p><p align="justify"><u>Select oil/gas related names showing weakness:</u> SU -1.1%, E -1.1%, RDS.A -0.9%, HAL -0.9%.</p><p align="justify"><u>Other news</u>: FRX -9.2% (US FDA Panel data do not support approval of Forest, Nycomed lung drug Daxas for COPD maintenance - Reuters; downgraded to Hold from Buy at Lazard, downgraded to Underweight from Neutral at Piper Jaffray), WZE -8.0% (light volume; announced that its audited financial statements contained a going concern qualification), AIXG -4.4% (still checking), DGIT -4.1% (prices 3.175 mln share common stock offering at $31.50/share ), MFA -3.9% (trading ex dividend), VHC -2.3% (report of its independent public accounting firm contains a "going concern" qualification), BEXP -1.6% (prices offering of 14,000,000 shares of common stock at $18 per share), PNW -1.5% (commenced a public offering of 6 mln shares of its common stock), RF -1.0% (Morgan Keegan responds to regulatory actions; intends to defend rigorously against charges).</p><p align="justify"><u>Analyst comments</u>: KEY -2.0% (downgraded to Underperform from Neutral at Baird), ELX -2.0% (downgraded to Hold from Buy at Canaccord), FDO -2.0% (downgraded to Underweight from Neutral at Piper Jaffray), EBAY -1.8% (downgraded to Hold from Buy at Kaufman), EMC -1.5% (downgraded to Hold from Buy at Canaccord).</p>